metallothionein and fluorexon

metallothionein has been researched along with fluorexon* in 1 studies

Other Studies

1 other study(ies) available for metallothionein and fluorexon

ArticleYear
Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells.
    FEBS letters, 1999, Jan-29, Volume: 443, Issue:3

    Cellular and molecular mechanisms involved in the resistance to cytotoxic heavy metals remain largely to be characterized in mammalian cells. To this end, we have analyzed a metal-resistant variant of the human lung cancer GLC4 cell line that we have selected by a step-wise procedure in potassium antimony tartrate. Antimony-selected cells, termed GLC4/Sb30 cells, poorly accumulated antimony through an enhanced cellular efflux of metal, thus suggesting up-regulation of a membrane export system in these cells. Indeed, GLC4/Sb30 cells were found to display a functional overexpression of the multidrug resistance-associated protein MRP1, a drug export pump, as demonstrated by Western blotting, reverse transcriptase-polymerase chain reaction and calcein accumulation assays. Moreover, MK571, a potent inhibitor of MRP1 activity, was found to markedly down-modulate resistance of GLC4/Sb30 cells to antimony and to decrease cellular export of the metal. Taken together, our data support the conclusion that overexpression of functional MRP1 likely represents one major mechanism by which human cells can escape the cytotoxic effects of heavy metals.

    Topics: Antimony; Antineoplastic Agents; Arsenites; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Blotting, Western; Cadmium Chloride; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Gene Amplification; Humans; Inhibitory Concentration 50; Lung Neoplasms; Meglumine; Metallothionein; Metals, Heavy; Multidrug Resistance-Associated Proteins; Propionates; Quinolines; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation; Zinc Sulfate

1999